Yang J - Search Results

1

The Impact of Biosimilar Use on Total Cost of Care and Provider Financial Performance in the Medicare Oncology Care Model: A Population-Based Simulation Study.

Yang J, Chaudhry BI, Yue AT, Roth JA, Kelton JM, Shelbaya A, Tran L, Li M. Yang J, et al. Adv Ther. 2024 Jan;41(1):349-363. doi: 10.1007/s12325-023-02703-x. Epub 2023 Nov 14. Adv Ther. 2024. PMID: 37957523 Free PMC article.

2

Yang J, Liu R, Ektare V, Stephens J, Shelbaya A. Yang J, et al. Appl Health Econ Health Policy. 2021 Jul;19(4):605-618. doi: 10.1007/s40258-021-00637-5. Epub 2021 Jan 28. Appl Health Econ Health Policy. 2021. PMID: 33506318 Free PMC article.

3

Real-world use and acceptance of biosimilar monoclonal antibodies of rituximab in oncology practice in the USA.

Shelbaya A, Kelton JM, Thompson J, Alvir JM, Maculaitis MC, Yang J. Shelbaya A, et al. Among authors: yang j. Future Oncol. 2021 Oct;17(30):3941-3950. doi: 10.2217/fon-2021-0618. Epub 2021 Jul 14. Future Oncol. 2021. PMID: 34259584

4

Greater uptake, an alternative reimbursement methodology needed to realize cost-saving potential of oncology biosimilars in the United States.

Yang J, Carioto J, Pyenson B, Smith R, Jacobson N, Pittinger S, Shelbaya A. Yang J, et al. J Manag Care Spec Pharm. 2021 Dec;27(12):1642-1651. doi: 10.18553/jmcp.2021.21202. Epub 2021 Oct 22. J Manag Care Spec Pharm. 2021. PMID: 34677089 Free PMC article.

5

Evolving Perceptions, Utilization, and Real-World Implementation Experiences of Oncology Monoclonal Antibody Biosimilars in the USA: Perspectives from Both Payers and Physicians.

Yang J, Blinzler K, Lankin J, Vijayakumar S, Maculaitis MC, Shelbaya A. Yang J, et al. BioDrugs. 2022 Jan;36(1):71-83. doi: 10.1007/s40259-021-00509-3. Epub 2021 Nov 25. BioDrugs. 2022. PMID: 34822141 Free PMC article.

6

Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia.

Cornes P, Kelton J, Liu R, Zaidi O, Stephens J, Yang J. Cornes P, et al. Among authors: yang j. Future Oncol. 2022 Mar 31. doi: 10.2217/fon-2022-0095. Online ahead of print. Future Oncol. 2022. PMID: 35354304

7

Real-world usage of bevacizumab-bvzr biosimilar in US oncology practice.

Yang J, Kelton JM, Thompson J, Alvir JMJ, Maculaitis MC, Shelbaya A. Yang J, et al. Am J Manag Care. 2022 Apr;28(4):160-166. doi: 10.37765/ajmc.2022.88831. Am J Manag Care. 2022. PMID: 35420744 Free article.

8

Yang J, Liu R, Granghaud A, Zaidi O, Stephens J. Yang J, et al. J Med Econ. 2021 Jan-Dec;24(1):665-674. doi: 10.1080/13696998.2021.1922252. J Med Econ. 2021. PMID: 33904357 Free article.

9

Impact of vaccination and non-pharmacological interventions on COVID-19: a review of simulation modeling studies in Asia.

Thakkar K, Spinardi JR, Yang J, Kyaw MH, Ozbilgili E, Mendoza CF, Oh HML. Thakkar K, et al. Among authors: yang j. Front Public Health. 2023 Sep 25;11:1252719. doi: 10.3389/fpubh.2023.1252719. eCollection 2023. Front Public Health. 2023. PMID: 37818298 Free PMC article. Review.

10

Health Care Resource Utilization and Costs Associated With COVID-19 Among Pediatrics Managed in the Community or Hospital Setting in England: A Population-based Cohort Study.

Yang J, Andersen KM, Rai KK, Tritton T, Mugwagwa T, Tsang C, Reimbaeva M, McGrath LJ, Payne P, Backhouse B, Mendes D, Butfield R, Wood R, Nguyen JL. Yang J, et al. Pediatr Infect Dis J. 2024 Mar 1;43(3):209-216. doi: 10.1097/INF.0000000000004213. Epub 2023 Dec 18. Pediatr Infect Dis J. 2024. PMID: 38113517

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91,158 results

Search Page

Filters